7 February 2019

Seyed Qaderi and Hans de Wilt together with the department of Surgical Oncology developed and implemented a new patient centered follow up schedule for colorectal cancer survivors.

After treatment, colorectal cancer patients remain under surveillance in the hospital for at least 5 years. This is performed according to the national guidelines.
The purpose of these appointments is to screen for symptoms and explore patient wellbeing, and to detect metastases or recurrent disease as early as possible.
 
Research demonstrates that periodic outpatient clinic visits are not always useful. It leads to long waiting times and it can lead to more (unnecessary) treatments, anxiety among patients and higher healthcare costs without improving patient survival.
Patient organizations and health professionals call for new patient-oriented follow up schedules. In these new schemes emphasis should be on quality of life, attention to the consequences of operative interventions on daily life, psychosocial wellbeing.
 
More involvement of patients in decision making and follow up improves the emotional and social well-being of patients and gives the patient more autonomy and (self-) confidence.
 
The follow up policy of colorectal cancer patients treated at Radboudumc has changed. After being followed, undergoing the necessary tests in the first year, patients do not longer have to come to the hospital for the results of the tests hereafter. The results will be made available through our electronic mijnRadboud platform in a patient-friendly manner. When experiencing symptoms, having questions, or noticing abnormal test results, patients are advised to call our nurse practitioner and when necessary, telephone, video-chat, or a physical clinical visit will be planned.
 
With adequate patient training and written information and instructions on what to do and when to do (self management), we aim at increasing patient involvement and satisfaction during bowel cancer follow up!
 
More information can be found (in Dutch): www.radboudumc.nl/darmkanker

 Seyed Qaderi and Hans de Wilt are both members of theme Tumors of digestive tract.
  • Want to know more about these subjects? Click on the buttons below for more news.

    Surgery

Related news items


Increased role of patients after bowel cancer treatment

30 July 2020 Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer. read more

Laparoscopy reduces the number of adhesions but it is still too high

14 January 2020 Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues. read more

Secure trial usual care to a restrictive patient selection for gallbladder surgery

23 May 2019 In Lancet Kees van Laarhoven and colleagues showed that usual care for gallstone patients is suboptimal and that less than two third of patients are pain-free after surgery. read more

Valentine’s day spectacle at the Radboud Research Rounds

21 February 2019 This year’s Valentine’s day in the Radboudumc was focused on the RRR of the Tumors of the Digestive Tract. In the biannual Paper Award session the big prize went to Daniel Garza from the Center for Molecular and Biomolecular Informatics, for his paper on “the environmental metabolome”. read more

Radiotherapy-associated angiosarcoma after breast cancer treatment

7 February 2019 In Jama Oncology Anouk Rombouts and co-workers showed that one in 1000 patients who were treated with radiotherapy for breast cancer will develop an angiosarcoma of the breast. read more

MLDS grant for development of cine-MRI for diagnosis of post-operative adhesions

7 February 2019 Richard ten Broek and co-workers have received a €150K grant from MLDS for further development of cineMRI to diagnose adhesions. read more